Continue to site >
Trending ETFs

The Cannabis ETF

ETF
THCX
Payout Change
Suspended
Price as of:
$3.45 +0.15 +4.55%
primary theme
Sector Diversified Equity
THCX (ETF)

The Cannabis ETF

Payout Change
Suspended
Price as of:
$3.45 +0.15 +4.55%
primary theme
Sector Diversified Equity
THCX (ETF)

The Cannabis ETF

Payout Change
Suspended
Price as of:
$3.45 +0.15 +4.55%
primary theme
Sector Diversified Equity

Name

Price

Aum/Mkt Cap

YIELD

Exp Ratio

Watchlist

The Cannabis ETF

THCX | ETF

$3.45

$41.2 M

0.00%

$0.00

0.75%

Vitals

YTD Return

-59.6%

1 yr return

-62.6%

3 Yr Avg Return

-33.7%

5 Yr Avg Return

N/A

Net Assets

$41.2 M

Holdings in Top 10

57.8%

52 WEEK LOW AND HIGH

$3.3
$2.75
$10.05

Expenses

OPERATING FEES

Expense Ratio 0.75%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 54.09%

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Exchange Traded Fund

Investment Style

Miscellaneous Sector


Name

Price

Aum/Mkt Cap

YIELD

Exp Ratio

Watchlist

The Cannabis ETF

THCX | ETF

$3.45

$41.2 M

0.00%

$0.00

0.75%

THCX - Profile

Distributions

  • YTD Total Return -59.6%
  • 3 Yr Annualized Total Return -33.7%
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio -0.25%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    The Cannabis ETF
  • Fund Family Name
    Innovation Shares
  • Inception Date
    Jul 09, 2019
  • Shares Outstanding
    N/A
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Michael Obuchowski

Fund Description

The fund will invest at least 80% of its total assets in the component securities of the index. It will also invest, under normal circumstances, at least 80% of its net assets, plus borrowings for investment purposes, in exchange listed common stock (or corresponding American Depositary Receipts ("ADRs") of Cannabis Companies. The index is a proprietary, rules-based index designed to track the performance of a portfolio of Cannabis Companies. The fund is non-diversified.


THCX - Performance

Return Ranking - Trailing

Period THCX Return Category Return Low Category Return High Rank in Category (%)
YTD -59.6% -59.6% 27.3% 100.00%
1 Yr -62.6% -68.1% 24.3% 93.48%
3 Yr -33.7%* -40.9% 43.4% 92.31%
5 Yr N/A* -24.2% 29.9% N/A
10 Yr N/A* -1.2% 21.9% N/A

* Annualized

Return Ranking - Calendar

Period THCX Return Category Return Low Category Return High Rank in Category (%)
2021 -31.7% -39.3% 28.3% 97.67%
2020 2.1% -16.6% 82.7% 70.00%
2019 N/A -31.4% 35.7% N/A
2018 N/A -23.4% 1.6% N/A
2017 N/A -1.4% 34.6% N/A

Total Return Ranking - Trailing

Period THCX Return Category Return Low Category Return High Rank in Category (%)
YTD -59.6% -73.0% 27.3% 96.67%
1 Yr -62.6% -68.1% 24.3% 93.48%
3 Yr -33.7%* -40.9% 43.4% 92.31%
5 Yr N/A* -24.2% 29.9% N/A
10 Yr N/A* 1.1% 21.9% N/A

* Annualized

Total Return Ranking - Calendar

Period THCX Return Category Return Low Category Return High Rank in Category (%)
2021 -31.7% -39.3% 28.3% 97.67%
2020 2.1% -16.6% 82.7% 70.00%
2019 N/A -31.4% 35.7% N/A
2018 N/A -23.4% 1.6% N/A
2017 N/A -1.4% 34.6% N/A

THCX - Holdings

Concentration Analysis

THCX Category Low Category High THCX % Rank
Net Assets 41.2 M 610 K 31.2 B 56.90%
Number of Holdings 27 1 389 91.18%
Net Assets in Top 10 23.7 M -21.4 M 5.86 B 52.94%
Weighting of Top 10 57.76% 8.9% 100.0% 35.94%

Top 10 Holdings

  1. Aphria Inc 7.56%
  2. AFC Gamma Inc Ordinary Shares 7.46%
  3. Cronos Group Inc 6.68%
  4. Aurora Cannabis Inc 6.53%
  5. Tilray Brands Inc 6.22%
  6. WM Technology Inc Ordinary Shares - Class A 5.58%
  7. Leafly Holdings Inc 5.53%
  8. Fire & Flower Holdings Corp Ordinary Shares 5.47%
  9. OrganiGram Holdings Inc 5.40%
  10. Amyris Inc 5.04%

Asset Allocation

Weighting Return Low Return High THCX % Rank
Stocks
100.00% 0.00% 100.33% 20.59%
Preferred Stocks
0.00% 0.00% 29.02% 88.24%
Other
0.00% -8.90% 91.95% 86.76%
Convertible Bonds
0.00% 0.00% 3.05% 88.24%
Cash
0.00% -0.34% 101.46% 91.18%
Bonds
0.00% 0.00% 88.23% 88.24%

Stock Sector Breakdown

Weighting Return Low Return High THCX % Rank
Healthcare
65.82% 0.00% 100.00% 5.08%
Real Estate
7.46% 0.00% 54.95% 18.64%
Consumer Defense
6.65% 0.00% 53.62% 27.12%
Basic Materials
6.29% 0.00% 36.59% 28.81%
Technology
5.58% 0.00% 77.79% 66.10%
Industrials
4.38% 0.00% 90.47% 61.02%
Consumer Cyclical
3.82% 0.00% 41.11% 62.71%
Utilities
0.00% 0.00% 85.14% 89.83%
Financial Services
0.00% 0.00% 95.51% 91.53%
Energy
0.00% 0.00% 32.10% 89.83%
Communication Services
0.00% 0.00% 16.38% 91.53%

Stock Geographic Breakdown

Weighting Return Low Return High THCX % Rank
US
56.20% 0.00% 85.31% 39.71%
Non US
43.80% 0.00% 98.35% 35.29%

THCX - Expenses

Operational Fees

THCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.75% 0.22% 4.26% 48.00%
Management Fee 0.95% 0.25% 1.90% 84.29%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.19% N/A

Sales Fees

THCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 2.25% N/A

Trading Fees

THCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 2.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

THCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 54.09% 0.00% 140.00% 76.47%

THCX - Distributions

Dividend Yield Analysis

THCX Category Low Category High THCX % Rank
Dividend Yield 0.00% 0.00% 9.73% 93.33%

Dividend Distribution Analysis

THCX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Quarterly Semi-Annually

Net Income Ratio Analysis

THCX Category Low Category High THCX % Rank
Net Income Ratio -0.25% -2.66% 5.19% 69.09%

Capital Gain Distribution Analysis

THCX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually

Distributions History

View More +

THCX - Fund Manager Analysis

Managers

Michael Obuchowski


Start Date

Tenure

Tenure Rank

Jul 09, 2019

2.9

2.9%

Dr. Michael Obuchowski is the Founder and Chief Investment Officer of Merlin Asset Management (MAM). He founded MAM in June 2012 to continue developing and managing modern investment strategies. During the last 18 years, he developed a range of large and SMID cap growth equity focused investment strategies with the longest GIPS track record starting at the end of 2012 when Dr. Obuchowski provided investment advisory services through North Shore Asset Management (NSAM). From February 2014 to August 2016, Dr. Obuchowski provided investment advisory services through CONCERT Wealth Management, Inc., where he was a Portfolio Manager and member of the Investment Committee. In August 2018, Merlin Asset Management registered with the SEC as an independent Investment Advisor. Before NSAM, in July 2008, Dr. Obuchowski helped establish First Empire Asset Management, Inc. (FEAM). As FEAM's Chief Investment Officer, he was responsible for the development and management of all equity-related investment strategies. While at FEAM, Dr. Obuchowski developed a range of top-ranked large-cap growth equity investment strategies. His FEAM50 strategy was ranked by Informa Investments Solutions PSN as one of the Top Gun Bull & Bear Master large-cap growth equity strategies for a 3-year return as of 6/30/2011. The same strategy was also ranked in Lipper's Top 40 Money Managers for 12 quarters ending 12/31/2010, 3/31/2011, and 6/30/2011. Before joining FEAM, he was a co-founder, Principal, and Portfolio Manager at Altanes Investments, LLC, a New York City-based boutique investment advisory company specializing in the large-capitalization US and global diversified investment strategies. At Altanes Investment, Dr. Obuchowski was responsible for the development and management of investment strategies, portfolio management, trading, compliance, and operations. Before moving to finance, Dr. Obuchowski spent 15 years in academic research in healthcare and biotechnology. He was an Assistant Professor of Psychiatry at the Albert Einstein College of Medicine in New York, Chief of Psychophysiology Unit at the Psychiatry Research Division at Hillside Hospital, and Associate Director of the Recognition and Prevention Program at Schneider Children's Hospital in Glen Oaks, NY.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.75 23.1 6.77 3.29